Clinical Trial Update: Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating supportive therapy in conjunction with androgen deprivation for prostate adenocarcinoma; study terminated with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of California, San Francisco | Conditions: Prostate Adenocarcinoma | Phase 2 | Status: TERMINATED | Results posted: 2020-06-01